SSTARBirth featured on WPRI 12 segment (Number of drug-dependent babies up sharply as clinicians look for treatment solutions). The most recent set of statistics from the Rhode Island Department of Health show just under 10 babies per 1,000 were born with Neonatal Abstinence Syndrome NAS in 2014, down slightly from 11 per thousand from the first quarter of that year. But the total nearly doubled the 4.4 per 1,000 rate from 2005.
SSTARbirth’s multidisciplinary team includes 30 staff members, including a Program Director, Clinical Supervisor, Mental Health Specialist, Substance Abuse Counselors, Case Managers, Parenting Trainer, Vocational Education Specialist, Head Teacher, Daycare Workers, as well as other support staff. In addition, SSTARbirth employs a daytime and evening driver to provide safe and timely transportation to appointments and minimize the disruption to treatment.
Neonatal Abstinence Syndrome (NAS) occurs because a pregnant woman takes opiate or narcotic drugs such as heroin, codeine, oxycodone (Oxycontin) methadone or buprenorphine. These and other substances pass through the placenta that connects the baby to its mother in the womb. The baby becomes addicted along with the mother. At birth, the baby is still dependent on the drug. Because the baby is no longer getting the drug after birth, symptoms of withdrawal may occur. For More Information: Neonatal Abstinence Syndrome (A Guide for Families)